These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32768016)

  • 21. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).
    Greenberg H; Case RB; Moss AJ; Brown MW; Carroll ER; Andrews ML;
    J Am Coll Cardiol; 2004 Apr; 43(8):1459-65. PubMed ID: 15093884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECG quantification of myocardial scar and risk stratification in MADIT-II.
    Loring Z; Zareba W; McNitt S; Strauss DG; Wagner GS; Daubert JP
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):427-35. PubMed ID: 24047486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.
    Pitschner HF; Neuzner J; Himmrich E; Liebrich A; Jung J; Heisel A
    J Interv Card Electrophysiol; 1997 Nov; 1(3):211-20. PubMed ID: 9869974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arrhythmias during remodeling after myocardial infarction].
    Bauer WR; Ertl G
    Herz; 2002 Dec; 27(8):740-9. PubMed ID: 12574891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria.
    An Y; Ando K; Soga Y; Nomura A; Nagashima M; Hayashi K; Makihara Y; Fukunaga M; Hiroshima KI; Nobuyoshi M; Goya M
    J Arrhythm; 2017 Feb; 33(1):17-22. PubMed ID: 28217224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
    Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.
    Boriani G; Botto G; Lunati M; Proclemer A; Schmidt B; Erdogan A; Rauhe W; Biffi M; Santi E; Becker D; Messier M; Santini M
    BMC Cardiovasc Disord; 2012 Sep; 12():72. PubMed ID: 22966862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Survival of Multicenter Automatic Defibrillator Implantation Trial (MADIT) II-Eligible Patients in Taiwan.
    Chang PC; Chen WT; Wo HT; Chen TH; Wen MS; Yeh SJ; Wang CC
    Acta Cardiol Sin; 2014 May; 30(3):229-35. PubMed ID: 27122793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
    Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
    Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Chen J; Johnson G; Hellkamp AS; Anderson J; Mark DB; Lee KL; Bardy GH; Poole JE
    J Am Coll Cardiol; 2013 May; 61(21):2161-8. PubMed ID: 23541974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
    Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC
    Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
    J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
    Sharma A; Al-Khatib SM; Ezekowitz JA; Cooper LB; Fordyce CB; Michael Felker G; Bardy GH; Poole JE; Thomas Bigger J; Buxton AE; Moss AJ; Friedman DJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Peterson ED; Inoue LYT; Sanders GD
    Eur J Heart Fail; 2018 Jun; 20(6):1031-1038. PubMed ID: 29761861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Death with an implantable cardioverter-defibrillator: a MADIT-II substudy.
    Chernomordik F; Jons C; Klein HU; Kutyifa V; Nof E; Zareba W; Daubert JP; Greenberg H; Glikson M; Goldenberg I; Beinart R
    Europace; 2019 Dec; 21(12):1843-1850. PubMed ID: 31647531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.